Abhilasha Singh: Lp(a) as a Long-Term Cardiovascular Risk Signal in Healthy Women
Abhilasha Singh, Review Editor at Frontiers in Stroke and Reviewer at Springer Nature Phytomedicine, shared on LinkedIn about a recent article by Ask Tybjærg Nordestgaard and et al, published in JAMA Cardiology:
“Lp(a): A 30-Year Cardiovascular Risk Signal We May Be Underestimating
A 30-year follow-up of ~27,000 initially healthy women (JAMA Cardiology, 2026) shows that elevated Lipoprotein(a) [Lp(a)] independently predicts long-term cardiovascular risk.
What the Data Show
- Lp(a) level of 30 mg/dL or higher is associated with an increased incidence of major adverse cardiovascular events.
- Lp(a) levels of 120 mg/dL or higher increase the risk of coronary heart disease, ischemic stroke, and cardiovascular death.
- Clear dose–response gradient
- Risk persists beyond traditional factors
- Lp(a) is largely genetically determined
Why This Matters Clinically
- Prevention remains centered on LDL-C
- Most 10-year risk models do not integrate Lp(a)
- ‘Normal cholesterol’ does not equal absence of inherited risk.
- Short-term prediction may miss lifelong exposure
Perspective
This study invites reconsideration of how we define and operationalize cardiovascular risk in the era of genomic medicine. ”
Title: Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)
Authors: Tybjærg Nordestgaard, Daniel I. Chasman, Vinayaga Moorthy, Jordan M. Kraaijenhof, Nancy R. Cook, I-Min Lee, Julie E. Buring, Paul M. Ridker
Read the Full Article on JAMA Cardiology .

Stay updated on all scientific advances with Hemostasis Today .
-
Sep 6, 2026, 13:33Antoine Francis: Albumin – The Donor Patient Equation
-
Sep 6, 2026, 12:5810 Posts Not to Miss This Week
-
Sep 6, 2026, 12:38Parveen Yograj: Atrial Fibrillation More Than an Irregular Heartbeat
-
Sep 6, 2026, 12:38Marsha McLeod: The Safety Question Behind Canada’s High-Frequency Plasma Donations
-
Sep 6, 2026, 12:27Alan Nurden: Inherited GPIV (CD36) Deficiency Linked to Bleeding for the First Time
-
Sep 6, 2026, 12:19Zaid Siddiqui: Hemophilia From a Broader Perspective
-
Sep 6, 2026, 12:13Claire Harrison: MPN Does Not Define Your Dreams
-
Sep 6, 2026, 12:12Ilenia Calcaterra: Beyond Bleeding Control Emicizumab and the Evolution of Joint Health in Hemophilia A
-
Sep 6, 2026, 12:11Agisilaos Zerdelis: My CRTH Journey From Trial Idea to Clinical Research